s6y
Company name or ticker
Search
Hamill John P.
3
Cellectar Biosciences, Inc.: Initial statement of beneficial ownership of securities
Filed
Friday, September 8, 2017
Period
Sep 5, 2017
Accession number
0001144204-17-047185
Documents
FORM 3
3
EXHIBIT 24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header